XML 49 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
MARKETABLE SECURITIES (Details Narrative)
$ / shares in Units, € in Millions
 1 Months Ended 9 Months Ended
Jul. 16, 2018
USD ($)
shares
May 17, 2018
USD ($)
shares
Sep. 30, 2022
USD ($)
$ / shares
shares
Sep. 30, 2022
CAD ($)
shares
Sep. 30, 2022
EUR (€)
shares
Dec. 31, 2021
USD ($)
Jun. 30, 2019
Net unrealized loss on fair value investment     $ 415        
Equity securities - Pancreta Bank [Member]              
Additional investments in equity securities     $ 5,053        
Marathon Global Inc. [Member] | Distribution And Equity Acquisition Agreement [Member]              
Equity interest acquired description     a 33 1/3% equity interest or 5 million shares in Marathon as partial consideration for the Company’s distribution services a 33 1/3% equity interest or 5 million shares in Marathon as partial consideration for the Company’s distribution services a 33 1/3% equity interest or 5 million shares in Marathon as partial consideration for the Company’s distribution services    
Cash received upon gross sales       $ 2,750,000      
Gross sales       6,500,000      
Marathon Global Inc. [Member] | Distribution And Equity Acquisition Agreement [Member] | Sales One [Member]              
Cash received upon gross sales       2,750,000      
Gross sales       $ 13,000,000      
National Bank of Greece [Member]              
Equity method investment shares acquired, shares | shares     16,666 16,666 16,666    
Closing price | $ / shares     $ 0.30        
Cosmo Farmacy LP [Member]              
Cash contributed to limited partner | €         € 150,000    
Initial share capital increased | €         500,000    
Pharmacy license value | €         € 350,000    
Maturity period of license     30 years 30 years 30 years    
Ownership equity             70.00%
Initial share capital | €         € 150,000    
Equity ownership remaining             30.00%
Investments     $ 146,745     $ 169,770  
Share Exchange Agreement [Member] | Equity securities - Pancreta Bank [Member]              
Additional investments in equity securities     5,053        
Share Exchange Agreement [Member] | Marathon Global Inc. [Member]              
Gain on exchange of investment $ 2,092,200 $ 1,953,000          
Shares of Marathon transferred by company to KBB | shares 2,500,000            
Share Exchange Agreement [Member] | Kaneh Bosm Biotechnology Inc [Member]              
Transfer of shares | shares   2,500,000          
Share Exchange Agreement [Member] | Kaneh Bosm Biotechnology Inc [Member] | Canadian Securities Exchange [Member]              
Exchange of shares | shares   5,000,000          
Share Exchange Agreement [Member] | ICC [Member]              
Net unrealized loss on fair value investment     0        
Investments     $ 0     $ 0  
Exchange of shares | shares 5,000,000            
Description for ownership percentage The ten million shares of ICC owned by the Company constituted approximately 7% of the 141,219,108 shares of capital stock of KBB then issued and outstanding. The Company does not have the ability to exercise significant influence over ICC.   Since no value was attributed to the 33 1/3% equity ownership interest in Marathon received as consideration for the distribution services, the Company would receive variable consideration in the future for its services under the Distribution and Equity Acquisition Agreement Since no value was attributed to the 33 1/3% equity ownership interest in Marathon received as consideration for the distribution services, the Company would receive variable consideration in the future for its services under the Distribution and Equity Acquisition Agreement Since no value was attributed to the 33 1/3% equity ownership interest in Marathon received as consideration for the distribution services, the Company would receive variable consideration in the future for its services under the Distribution and Equity Acquisition Agreement    
Additional shares issued, amount | shares     0        
Additional shares issued, shares | shares     3,000,000        
Share Exchange Agreement [Member] | National Bank of Greece [Member]              
Equity method investment shares acquired, value     $ 4,934        
Equity method investment shares acquired, shares | shares     16,666 16,666 16,666    
Closing price | $ / shares     $ 0.30